Bisphosphonate Use for Glucocorticoid-Induced Osteoporosis in Elderly Patients with Immune Thrombocytopenia Receiving Prolonged Steroid Therapy: A Single Institute Retrospective Study

MLA

Satoshi Yamasaki, et al. “Bisphosphonate Use for Glucocorticoid-Induced Osteoporosis in Elderly Patients with Immune Thrombocytopenia Receiving Prolonged Steroid Therapy: A Single Institute Retrospective Study.” Hematology Reports, vol. 14, no. 3, Sept. 2022, pp. 276–85. EBSCOhost, https://doi.org/10.3390/hematolrep14030039.

APA

Satoshi Yamasaki, Kenjiro Kamezaki, Yoshikiyo Ito, & Takahiko Horiuchi. (2022). Bisphosphonate Use for Glucocorticoid-Induced Osteoporosis in Elderly Patients with Immune Thrombocytopenia Receiving Prolonged Steroid Therapy: A Single Institute Retrospective Study. Hematology Reports, 14(3), 276–285. https://doi.org/10.3390/hematolrep14030039

Chicago

Satoshi Yamasaki, Kenjiro Kamezaki, Yoshikiyo Ito, and Takahiko Horiuchi. 2022. “Bisphosphonate Use for Glucocorticoid-Induced Osteoporosis in Elderly Patients with Immune Thrombocytopenia Receiving Prolonged Steroid Therapy: A Single Institute Retrospective Study.” Hematology Reports 14 (3): 276–85. doi:10.3390/hematolrep14030039.